Action POAI PREDICTIVE ONCOLOGY INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Predictive Oncology Inc.

Actions

POAI

US74039M3097

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 16/07/2024 		Varia. 5j. Varia. 1 janv.
1,14 USD +2,70 % Graphique intraday de Predictive Oncology Inc. +10,68 % -65,35 %
11/06 Predictive Oncology Inc. développe un nouveau système d'expression de cellules souches pour la production de récepteurs couplés aux protéines G fonctionnels et stables. CI
04/06 Predictive Oncology Inc. lance une nouvelle technologie cellulaire en 3D pour accélérer la découverte de médicaments thérapeutiques contre le cancer CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
Predictive Oncology Inc. Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
Predictive Oncology Inc. Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be presented at the 2024 American Society of Clinical Oncology Annual Meeting
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
Top Premarket Gainers
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Predictive Oncology Inc. Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology Annual Meeting
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q1 Revenue $419,646
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
Predictive Oncology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
Predictive Oncology : Material Agreement - Form 8-K
Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts
Investors Await Fed Rate Decision as US Futures Trend Lower in Wednesday's Premarket
Top Premarket Gainers
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action POAI
  4. Actualités Predictive Oncology Inc.
  5. Autres langues